Kenya has intensified efforts to regulate pharmaceuticals, focusing on product traceability, supply-chain security, and quality assurance to protect patient health. Dr. John Munyu, Chairperson of the Pharmacy and Poisons Board, emphasized the importance of regulatory systems in building public confidence during the 6th PharmaReg & MedDevReg AfriSummit 2026 in Nairobi. The summit, opened by Cabinet Secretary for Health Aden Duale, highlighted Kenya’s progress in aligning with global standards through initiatives like the World Health Organization’s Global Benchmarking Tool. Dr. Munyu stated that robust regulations ensure medicines are “properly assessed, safely stored, and supplied through legitimate channels,” underscoring the need for consistency and risk-based decision-making in regulatory processes.
The Pharmacy and Poisons Board has implemented measures to renew marketing authorizations, ensuring ongoing oversight of health products beyond initial approval. It has also expanded inspections of manufacturers, wholesalers, and distribution points to safeguard quality throughout the supply chain. Dr. Munyu noted the board’s focus on advancing product authentication and traceability, enabling regulators to monitor medicines across distribution networks and respond swiftly to safety concerns. Additionally, the board is leveraging regulatory reliance, using assessments from trusted international authorities to inform national decisions, thereby streamlining evaluations while maintaining rigorous standards.
Dr. Munyu called for enhanced collaboration among African regulatory bodies, stating that challenges like substandard medical products, digital systems, and supply-chain security require collective action. He urged stakeholders to prioritize regulatory maturity, local manufacturing, and shared digital infrastructure to strengthen regional resilience. The summit, attended by Principal Secretary for Medical Services Dr. Ouma Oluga, Pharmacy and Poisons Board CEO Dr. Ahmed Mohamed, and representatives from across Africa, serves as a platform for knowledge exchange and partnership-building to advance practical regulatory reforms. These efforts aim to ensure transparency, efficiency, and accountability in pharmaceutical governance.
The reforms reflect Kenya’s commitment to addressing public health risks while fostering trust in medical systems. By integrating technical capacity, legal frameworks, and international cooperation, the nation seeks to prevent the circulation of substandard or falsified medicines. The Pharmacy and Poisons Board’s initiatives, supported by the AfriSummit’s collaborative approach, underscore the critical role of regulatory oversight in safeguarding patient welfare and advancing healthcare equity across the continent.